Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli

Virology Journal

Volumn 6, Issue , 2009, Pages

  Donayre Torres, Alberto J ^a   Esquivel Soto, Ernesto ^b   Gutiérrez Xicoténcatl, María De Lourdes ^c   Esquivel Guadarrama, Fernando R ^b   Gámez Lim, Miguel A ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ASIALOFETUIN; CARBOHYDRATE; CHIMERIC PROTEIN; CHOLERA TOXIN; CORE PROTEIN; FREUND ADJUVANT; GAG PROTEIN; LECTIN; RICIN; RICIN B; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; P24 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; VIRUS ANTIBODY;

AFFINITY CHROMATOGRAPHY; ARTICLE; BIOLOGICAL ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EUKARYOTE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGY; INOCULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; GENE EXPRESSION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN ENGINEERING; VIROLOGY;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; RICIN;

EID: 62149131329     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-17     Document Type: Article

References (28)

1. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p24 of B- and C-subtypes. S Gupta K Arora A Gupta VK Chaudhary, Prot Express Pur 2000 19 321 328 10.1006/prep.2000.1266
2. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector. DM Pérez-Filgueira BP Brayfield S Phiri MV Borca C Wood TJ Morris, J Virol Methods 2004 121 201 208 10.1016/j.jviromet.2004.06.022 15381357
3. Recombinant HIV-1 p24 protein: cloning, expression, purification and use in the development of ELISA kits. D Bhardwaj S Bhatt BM Khamar RI Modi P Ghosh, Curr Sci 2006 91 913 917
4. p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. R Sutthent N Gaudart K Chokpaibulkit N Tanliang C Kanoksinsombath P Chaisilwatana, J Clin Microbiol 2003 41 1016 1022 12624024 10.1128/JCM.41.3.1016-1022.2003
5. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1. A Pajot A Schnuriger A Moris A Rodallec DM Ojcius B Autran FA Lemmonnier YC Lone, Eur J Immunol 2007 37 2635 2644 10.1002/eji.200636819 17668896
6. In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune). RB Moss MR Wallace P Lanza W Giermakowska FC Jensen G Theofan C Chamberlin SP Richieri DI Carlo, Clin Diagn Lab Immunol 1998 5 3 308 312 9605982
7. HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. P Obregon D Chargelegue PM Drake A Prada J Nuttall L Frigerio JK Ma, Plant Biotech J 2006 4 195 207 10.1111/j.1467-7652.2005.00171.x
8. Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization. AB Kran M Sommerfelt B Sorensen J Nyhus I Baksaas J Bruun D Kvale, Vaccine 2005 23 4011 4015 10.1016/j.vaccine.2005.03. 010 15963359
9. The lectin gene family of Ricinus communis: cloning of a functional ricin gene and three lectin pseudogenes. JW Tregear LM Roberts, Plant Mol Biol 1992 18 515 525 10.1007/BF00040667 1371405
10. Ribosome-inactivating proteins from plants: more than RNA N-glycosidases? WJ Peumans Q Hao EJ van Damme, FASEB J 2001 15 1493 1506 10.1096/fj.00-0751rev 11427481
11. Ricin: the endoplasmic reticulum connection. LM Roberts DC Smith, Toxicon 2004 44 469 472 10.1016/j.toxicon.2004.07.002 15450920
12. The history of ricin, abrin and related toxins. S Olsnes, Toxicon 2004 44 361 370 10.1016/j.toxicon.2004.05.003 15302520
13. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. K Sandvig B van Deurs, FEBS Letters 2002 529 49 53 10.1016/S0014-5793(02)03182-4 12354612
14. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. K Suzue RA Young, J Immunol 1996 156 873 879 8543845
15. Synthesis and assembly of SIVmac Gag p27 core protein cholera toxin B subunit fusion protein in transgenic potato. TG Kim A Gruber RM Ruprecht WH Langridge, Mol Biotech 2004 28 33 40 10.1385/MB:28:1:33
16. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen. R Ulrich GP Borisova E Gren I Berzin P Pumpen R Eckert V Ose H Siakkou EJ Gren R von Baehr DH Krugr, Arch Virol 1992 126 321 328 10.1007/BF01309705 1381912
17. Ricin toxin B subunit enhancement of rotavirus NSP4 immunogenicity in mice. NW Choi MK Estes WH Langridge, Viral Immunol 2006 19 54 63 10.1089/vim.2006.19.54 16553550
18. Penetration of protein toxins into cells. P Falnes K Sandvig, Curr Opin Cell Biol 2000 12 407 413 10.1016/S0955-0674(00)00109-5 10873820
19. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants. C Swimmer SM Lehar J MacCafferty D Chiswell WA Blattler B Guild, Proc Nat Acad Sci USA 1992 89 3756 3760 1373889 10.1073/pnas.89.9.3756
20. Nasal delivery of antigen with the B subunit of Escherichia coli heat-labile enterotoxin augments antigen-specific T-cell clonal expansion and differentiation. M Apostolaki N Williams, Infect Immun 2004 72 4072 4080 15213152 10.1128/IAI.72.7.4072-4080.2004
21. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. L Freytag JD Clements, Vaccine 2005 23 1804 1813 10.1016/j.vaccine.2004.11.010 15734046
22. Vaccination strategies for mucosal immune responses. PL Ogra H Faden RC Welliver, Clin Microbiol Rev 2001 14 430 445 11292646 10.1128/CMR.14.2.430-445. 2001
23. Lectin binding patterns in rat nasal-associated lymphoid tissue (NALT) and the influence of various types of lectin on particle uptake in NALT. S Takata O Ohtani Y Watanabe, Arch Histol Cytol 2000 63 305 312 10.1679/aohc.63.305 11073062
24. Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells. C Burbage EP Tagge B Harris P Hall T Fu MC Willingham AE Frankel, Leukemia Research 1997 21 681 90 10.1016/S0145-2126(97)00043-X 9301690
25. IL2-ricin fusion toxin is selectively cytotoxic in vitro to IL2 receptor-bearing tumor cells. A Frankel E Tagge J Chandler C Burbage G Hancock J Vesely M Willingham, Bioconjugate Chem 1995 6 666 672 10.1021/bc00036a002
26. Expression and secretion of a recombinant ricin immunotoxin from murine myeloma cells. CE Krek CA Ladino VS Goldmacher WA Blättler BC Guild, Protein Eng 1995 8 481 489 10.1093/protein/8.5.481 8532670
27. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis. JE Carter 3rd J Yu NW Choi J Hough D Henderson D He WH Langridge, Mol Biotech 2006 32 1 15 10.1385/MB:32:1:001
28. Synthesis of a ricin toxin B subunit-rotavirus VP7 fusion protein in potato. NW Choi MK Estes WH Langridge, Mol Biotech 2006 32 117 127 10.1385/MB:32:2:117